Artal Group S.A. - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 90 filers reported holding SPERO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$1,000,000
+169.5%
500,0000.0%0.04%
+115.0%
Q2 2022$371,000
-91.5%
500,0000.0%0.02%
-89.0%
Q1 2022$4,350,000
-45.7%
500,0000.0%0.18%
-16.1%
Q4 2021$8,005,000
-13.0%
500,0000.0%0.22%
+5.3%
Q3 2021$9,205,000
+31.9%
500,0000.0%0.21%
+45.1%
Q2 2021$6,980,000
-5.2%
500,0000.0%0.14%
+9.2%
Q1 2021$7,360,000
-24.1%
500,0000.0%0.13%
-37.5%
Q4 2020$9,695,000
+44.8%
500,000
-16.7%
0.21%
+27.6%
Q3 2020$6,696,000
-9.2%
600,000
+10.1%
0.16%
-20.9%
Q2 2020$7,374,000
+58.4%
545,040
-5.4%
0.21%
+4.6%
Q1 2020$4,654,000
-3.2%
576,000
+15.2%
0.20%
+5.9%
Q4 2019$4,808,000
-16.0%
500,000
-7.4%
0.19%
-18.8%
Q3 2019$5,724,000
-7.9%
540,0000.0%0.23%
-8.8%
Q2 2019$6,215,000
-19.1%
540,000
-10.0%
0.25%
-20.1%
Q1 2019$7,686,000
+108.3%
600,0000.0%0.31%
+129.2%
Q4 2018$3,690,000
-41.5%
600,0000.0%0.14%
-16.5%
Q3 2018$6,306,000
+22.8%
600,000
+71.4%
0.16%
+50.5%
Q2 2018$5,135,000
+2.9%
350,0000.0%0.11%
+75.8%
Q1 2018$4,988,000
+21.3%
350,0000.0%0.06%0.0%
Q4 2017$4,113,000350,0000.06%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,353,303$1,637,49713.93%
Anson Funds Management LP 4,159,572$5,033,0821.01%
OUP Management Co., LLC 249,070$301,3750.68%
Atlas Venture Life Science Advisors, LLC 1,013,438$1,226,2600.19%
Murchinson Ltd. 862,700$1,043,8670.13%
Alphabet Inc. 889,979$1,076,8740.07%
AWM Investment Company, Inc. 333,400$403,4140.06%
DAFNA Capital Management LLC 125,000$151,2500.05%
Novo Holdings A/S 468,902$567,3710.04%
XTX Topco Ltd 58,368$70,6250.01%
View complete list of SPERO THERAPEUTICS INC shareholders